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Innermembrane proteins (IMPs) of Escherichia coli use different
pathways for membrane targeting and integration. YidC plays an
essential but poorly defined role in the integration and folding of
IMPs both in conjunction with the Sec translocon and as a Sec-
independent insertase. Depletion of YidC only marginally affects
the insertion of Sec-dependent IMPs, whereas it blocks the inser-
tion of a subset of Sec-independent IMPs. Substrates of this latter
“YidC-only” pathway include the relatively small IMPs M13 pro-
coat, Pf3 coat protein, and subunit c of the F1F0ATPase. Recently, it
has been shown that the steady state level of the larger and more
complex CyoA subunit of the cytochrome o oxidase is also severely
affected upon depletion of YidC. In the present study we have ana-
lyzed the biogenesis of the integral lipoprotein CyoA. Collectively,
our data suggest that the first transmembrane segment of CyoA
rather than the signal sequence recruits the signal recognition par-
ticle for membrane targeting. Membrane integration and assembly
appear to occur in two distinct sequential steps. YidC is sufficient to
catalyze insertion of the N-terminal domain consisting of the signal
sequence, transmembrane segment 1, and the small periplasmic
domain in between. Translocation of the large C-terminal periplas-
mic domain requires the Sec translocon and SecA, suggesting that
for this particular IMP the Sec translocon might operate down-
stream of YidC.
In Escherichia coli, IMPs4 are targeted and inserted into the inner
membrane via different pathways (1). Targeting of most IMPs analyzed
until now depends on a conserved system consisting of the signal rec-
ognition particle (SRP) and its receptor FtsY (2, 3). The E. coli SRP,
which consists of a signal sequence binding protein (Ffh for Fifty-four
homologue) and a 4.5 S RNA, samples nascent chains at the ribosomal
exit site for the presence of particularly hydrophobic targeting signals
that are primarily present in nascent IMPs. The ribosome nascent
chain-SRP complex is transferred to the Sec translocon located in the
inner membrane by the SRP receptor FtsY that is located both in the
cytoplasm and inner membrane. The mechanism of transfer by FtsY is
not well understood but most likely involves interaction of FtsY with
membrane lipids andwith the Sec translocon component SecY (4). GTP
binding and hydrolysis by Ffh and FtsY regulates the vectorial transfer
process and recycling of the components involved (5). The heterotrim-
eric core of the Sec translocon comprises the integral membrane com-
ponents SecY, SecE, and SecG. It functions in membrane insertion of
most IMPs and in translocation of secretory proteins (6). The peripheral
ATPase SecA is dynamically associated with the cytoplasmic side of the
SecYEG core and drives the translocation of secretory proteins and
large periplasmic domains of IMPs (7).
YidC has been identified as a novel Sec-associated component by
cross-link and pull-down experiments and plays a role in the biogenesis
of IMPs (8). In vivo depletion of YidC (which is an essential protein)
generally does not affect protein translocation and only slightly affects
the insertion of Sec-dependent IMPs into the membrane (9, 10). The
function of Sec-associated YidC has been investigated for only a limited
number of IMPs and is currently not well understood. Available evi-
dence suggests that it acts downstreamof the Sec translocon to facilitate
the lateral transfer and assembly of TMs and to assist the folding of
polytopic IMPs (9, 11–13).
On the other hand, TMs in Sec-dependent nascent IMPs contact
YidC very early in biogenesis, suggesting an additional role in the recep-
tion and recognition of TMs in the context of the Sec translocon (14,
15). The versatility of YidC is emphasized by the fact that it also func-
tions independent of the Sec translocon (16, 17). Depletion of YidC
almost completely inhibits membrane insertion of the Sec-independent
small Pf3 andM13 phage coat proteins that were initially considered to
insert spontaneously into the membrane (18). In vitro reconstitution
studies have shown that YidC is not only required but also sufficient for
membrane insertion of Pf3 coat protein including the translocation of
its small N-terminal domain (16). It is as yet not clear if this Sec-inde-
pendent insertase function of YidC is also reflected in a physical sepa-
ration of a fraction of YidC from the Sec translocon.
A recent study has shown that the loss of YidC rapidly leads to severe
defects in the functional assembly of cytochrome o oxidase and the
F0F1-ATPase complex (19). Specifically, the amount of F0c (subunit c of
the F0F1-ATPase) and CyoA (subunit of the cytochrome o oxidase)
decreased rapidly upon the depletion of YidC reminiscent of the effect
on the insertion of small phage coat proteins. YidC is homologous to the
mitochondrial OxaI that mediates membrane insertion of the mito-
chondrial IMPs Atp9 and Cox2p that are, in turn, homologous to F0c
and CyoA. Hence, it has been suggested that YidC plays a pivotal, per-
haps exclusive role in the membrane insertion of (domains of) F0c and
CyoA (19). Three independent studies indeed demonstrate that YidC,
but not the SecYEG complex, is required formembrane insertion of F0c,
a double spanning IMP with very short periplasmic tails at the N and C
termini (20–22). In contrast to F0c, CyoA is a lipoprotein that is initially
synthesized with a signal sequence containing a conserved “lipobox”
sequence that includes the signal peptidase II (SPaseII) cleavage site
(23). Like F0c, mature CyoA has two closely spaced TMs, but unlike F0c,
the second TM is followed by a large translocated domain.
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In the present study we have analyzed the targeting and insertion of
CyoA using complementary in vivo protease mapping experiments and
an in vitro photocross-linking technique. Collectively, our data demon-
strate that the SRP interacts with the first TMof CyoA (rather thanwith
its signal sequence) tomediate targeting of CyoA to the Sec/YidC inser-
tion site in the inner membrane. Membrane insertion appears to take
place in two distinct stages. YidC is required and sufficient for mem-
brane assembly of the N-terminal part of the protein, whereas translo-
cation of the large C-terminal periplasmic domain requires the Sec
translocon, including SecA. This suggests that for membrane assembly
of CyoA, the Sec translocon operates downstream of YidC.
EXPERIMENTAL PROCEDURES
Reagents, Enzymes, and Sera—Restriction enzymes, Expand long tem-
plate PCR system, and Lumi-LightPLUS Western blotting substrate were
from Roche Applied Science. Megashort script T7 transcription kit was
from Ambion Inc. [35S]Methionine and protein A-Sepharose were from
Amersham Biosciences. T4 ligase and alkaline phosphatase were from
Invitrogen. Pansorbin was fromMerck. All other chemicals were supplied
by Sigma.The SPaseII inhibitor globomycinwas fromour own stock.Anti-
sera against YidC, Ffh, Trigger factor, OmpA, CyoA, and SecY have been
described previously or were from our own collection (20, 24). Antiserum
against influenza hemagglutinin (HA) was from Sigma.
Strains, Plasmids, and Growth Conditions—E. coli strain MRE600 was
used to prepare a lysate for translation of in vitro synthesizedmRNAand
suppression ofUAGstop codons in the presence of (Tmd)Phe-tRNAsup.
Strain MC4100 was used for the preparation of inverted membrane
vesicles. Strain Top10F’ (Invitrogen) was used as routine host for all
plasmid constructs. The 4.5 S RNA depletion strain FF283, the SecE
depletion strain CM124, and the YidC depletion strain JS7131 were
grown as described (10). The temperature-sensitive amber suppressor
YidC depletion strain KO1672 and its isogenic control strain were
grown as described (25). The Ffh depletion strain HDB51, strain HTP-
406, which expresses a mutant ffh allele, and its control strain JP313
were grown as described previously (26, 27). The temperature-sensitive
SecY24 mutant IQ85 and its isogenic parent strain IQ86 (28) were cul-
tured overnight in M9 minimal medium at 30 °C. To inactivate SecY,
overnight cultures were back-diluted 1:50 and grown to early log phase
at 42 °C in the same medium. All strains were routinely grown in Luria
Bertani medium unless indicated otherwise.Where appropriate, antibi-
otics were added to the culture medium.
For in vivo protease accessibility assays, the cyoA gene was PCR-
amplified from E. coli K-12 genomic DNA including an HA tag (Tyr-
Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala) preceded by a flexible linker pep-
tide (Pro-Gly-Gly) at the C terminus of CyoA. The PCR fragment was
cloned into pC4Meth (24), yielding pC4Meth-CyoA-HA. Subsequently,
CyoA-HA coding sequences were introduced into pEH1, pEH3 (29),
and into pASKIBA3 (IBA GmbH) to allow expression in strains of dif-
ferent genetic background. The plasmid pEH1-CyoA-wt, encoding the
wild-type protein, was constructed by PCR using pC4Meth-CyoA-HA
as the template. pEH1-CyoA-HA77–315, encoding a truncated CyoA
derivative, was constructed in a PCR-based approach using pC4Meth-
CyoA-HA as template. CyoA-HA77–315 comprises residues 1–76
fused to a C-terminal HA tag preceded by the flexible linker peptide
(Pro-Gly-Gly) and a Lys-Lys-Lys-Lys stretch.
For in vitro cross-link experiments, the plasmids pC4Meth-118CyoA-
TAG56 and pC4Meth-54CyoA-TAG10 were constructed by nested
PCR as described (24) using pC4Meth-CyoA-HA as template. The plas-
mids encode a truncated CyoA of 118 and 54 amino acids, respectively,
including a C-terminal 4methionine tag to improve the labeling effi-
ciency. Moreover, the CyoA derivatives contain an amber mutation at
position 56 or 10 to allow sup-tRNA-mediated incorporation of a pho-
tocross-linking probe, as described (24). The nucleotide sequence of all
constructs was confirmed by DNA sequencing.
Assay for in Vivo Membrane Assembly—Strains MC4100, HDB51,
FF283, HTP406, JP313, IQ85, IQ86, CM124, JS713, KO1670, and
KO1672 were grown to early log phase. Cells harboring derivatives
of pEH1 or pEH3 (MC4100, HDB51, IQ85, IQ86, CM124, JS7131,
KO1670, and KO1672) were induced for 3 min by adding isopropyl
1-thio--D-galactopyranoside (1mM), and cells harboring derivatives of
pASKIBA3 (FF283, HTP406 and JP313) were induced for 1 min by add-
ing anhydrotetracycline (500 ng/ml). Cells were labeled with [35S]me-
thionine (30 Ci/ml) and converted to spheroplasts as described previ-
ously (10). Aliquots of the spheroplast suspension were incubated with
or without proteinase K (0.3 mg/ml) for 1 h on ice. Subsequently, phen-
ylmethylsulfonyl fluoride (0.33 mg/ml) was added to the spheroplast
suspension to inhibit proteinase K. Finally, proteins were acid-precipi-
tated and immunoprecipitated with antisera against OmpA, Trigger
factor, or the HA tag (24). Samples were analyzed by SDS-PAGE, and
proteins were visualized by phosphorimaging. When indicated, the
SPaseII inhibitor globomycin (100 g/ml) was added 5 min before
induction, or sodium azide (2 mM) was added 4min before induction to
block SecA function.
Sodium Carbonate Extraction of Cells—Strain JS7131 harboring
derivatives of pEH1 was grown to mid-log phase. Aliquots contain-
ing 1 A660 unit of cells were harvested and resuspended in 1 ml of M9
minimal medium. Isopropyl 1-thio--D-galactopyranoside (1 mM)
was added for 1 min to induce CyoA expression. Subsequently, cells
were pulse-labeled with [35S]methionine (30 Ci/ml), converted to
spheroplasts as described (10), and supplied with sodium carbonate
(0.2 M final concentration). Samples were vigorously vortexed, incu-
bated on ice for 15 min, and centrifuged (30 min at 110,000 g). The
carbonate-insoluble fraction was dissolved in 1% SDS and immuno-
precipitated with SecB, Lep, or HA antiserum (24). The carbonate
soluble fraction was acid-precipitated, dissolved in 1% SDS, and
immunoprecipitated. Samples were analyzed by SDS-PAGE, and
proteins were visualized by phosphorimaging.
In Vitro Cross-linking—TruncatedmRNAwas prepared as described
previously (24) from HindIII-linearized CyoA-derivative plasmids. For
photocross-linking, (Tmd)Phe was site-specifically incorporated into
CyoA nascent chains by suppression of an UAG stop codon using
(Tmd)Phe-tRNAsup in an E. coli in vitro translation system containing
[35S]methionine to label the nascent chains. Targeting to invertedmem-
brane vesicles, photocross-linking, and carbonate extraction were per-
formed as described (24). Carbonate-soluble and -insoluble fractions
were acid-precipitated or immunoprecipitated. Samples were analyzed
by SDS-PAGE and visualized by phosphorimaging as described (24).
RESULTS
Expression and Detection of CyoA—In the present study we have
investigated the targeting and membrane integration of CyoA. To per-
mit immunodetection in protease accessibility experiments, the nine-
amino acid-long influenza virusHA tag preceded by a flexible linker was
attached to the C terminus of the protein (Fig. 1A).We first verified that
addition of the tag does not interfere with the complex lipid
modification and processing of CyoA. Lipoproteins share a common
modification pathway by virtue of a conserved lipobox pentapeptide
that includes the N-terminal cysteine of the mature protein (30). The
lipoproteins are modified with diglyceride at the SH group of the cys-
teine, cleaved between the lipid-modified cysteine and the preceding
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amino acid by SPaseII, and acylated with fatty acid at the NH2 group of
the cysteine residue. SPaseII only cleaves lipid-modified precursor and
can be specifically inhibited by the antibiotic globomycin leading to the
accumulation of lipid-modified prolipoprotein.
Cells expressing wild-type or HA-tagged CyoA were pulse-labeled in
the absence or presence of globomycin, and CyoAwas immunoprecipi-
tated from the samples using antibodies against CyoA or the HA tag,
respectively. As shown in Fig. 1B, processing of both wild-type and
HA-tagged CyoA is almost completely inhibited by globomycin,
indicating that pre-CyoA-HA is lipid-modified and processed by
SPaseII, like wild-type CyoA. As expected, the HA-tagged CyoA species
migrate slightly slower than wild-type CyoA in SDS-PAGE. These data
indicate that attachment of an HA tag to the C terminus of CyoA does
not interfere with its processing and maturation, consistent with a
recent study using two other HA-tagged lipoproteins (25).
CyoA Is Targeted by the SRP to the Inner Membrane—Many IMPs
that have uncleaved signal anchor sequences require the SRP for effi-
cient targeting. To investigate the role of the SRP in targeting of CyoA,
which is synthesized with a cleavable signal sequence, we used a prote-
ase mapping assay to analyze membrane assembly of CyoA-HA in
strains in which the expression or activity of both components of the
SRP, Ffh and the 4.5 S RNA, can bemodulated. Cells of strain HDB51 in
which ffh expression is under control of an arabinose-inducible pro-
moter were grown in the presence or absence of arabinose, pulse-la-
beled, converted to spheroplasts, and treated with proteinase K to
degrade external (periplasmic) protein domains. As shown in Fig. 2A, in
the presence of Ffh mature CyoA-HA was only detected in mock-
treated samples, demonstrating that the HA tag is translocated and
sensitive to proteinase K. Apparently, theHA tag does not interferewith
membrane assembly of CyoA, validating our assay conditions. Trigger
factor (TF) and OmpA are cytoplasmic and outer membrane control
proteins used to monitor spheroplast formation and the efficacy of pro-
teinase K treatment, respectively. Depletion of Ffh resulted in accumu-
lation of protease-protected precursorCyo-HA, suggesting that the SRP
is required for targeting of CyoA to the inner membrane.
Translocation and processing of the Sec-dependent protein OmpA
were not affected under these conditions, indicating that inactivation of
the Sec translocon had not occurred. Protease insensitivity of a small
fraction of mature OmpA upon depletion of Ffh has been observed
before (20, 31) and remains to be investigated. Depletion of Ffh was
verified by analyzing the Ffh content in a cell sample taken before pulse-
labeling by immunoblotting (Fig. 2B). CyoA targeting was also analyzed
in the relatively mild and viable Ffh-87 mutant strain (27) (Fig. 2C).
Quantitation of the data in Fig. 2C (correcting for the methionine con-
tent of the precursor and mature forms) showed that the precursor
accumulated6-fold in cells of the Ffh-87mutantwhen comparedwith
cells of the wild-type control strain. OmpA processing was not affected
under these conditions, as expected for this SRP-independent protein.
A possible role for the SRP in CyoA targeting was further investigated in
the 4.5 S RNA depletion strain FF283. In accordance with the effects of
depletion of Ffh, depletion of 4.5 S RNA also resulted in precursor accu-
mulation (data not shown). Together, the results strongly suggest that
CyoA requires the SRP for efficient membrane targeting.
The SecYEG Translocon and SecA Are Required for Translocation of
the C-terminal Polar Domain of CyoA—The requirements for mem-
brane assembly of CyoA were studied using strains that are conditional
for the expression or activity of subunits of the Sec translocon and YidC
employing the same protease accessibility procedure. To evaluate the
role of the Sec translocon, we used the temperature-sensitive SecY
mutant IQ85 (and its isogenic parent strain IQ86) and the SecE deple-
tion strainCM124 inwhich the essential secE gene is under control of an
FIGURE 1. Membrane assembly of CyoA-HA. A, topology model of CyoA-HA. CyoA is
synthesizedwith a lipoprotein-type signal sequence that is processed by SPaseII (arrow).
Mature CyoA comprises two hydrophobic TMs connected by a small cytoplasmic loop
and two translocated termini; that is, a lipid-modifiedN terminus and a large C terminus.
An HA epitope tag is attached to the C terminus of CyoA to facilitate detection and
verification of membrane assembly. The HA tag is accessible to proteinase K added to
spheroplasts derived from wild-type cells. B, translocation and processing of pulse-la-
beled CyoA and CyoA-HA in wild-type cells in the absence or presence of the SPaseII
inhibitor globomycin. CyoA was immunoprecipitated with antisera against the wild-
type protein (-CyoA) or HA tag (-HA). The precursor andmature forms of CyoA-HA are
denoted p and m, respectively.
FIGURE 2. The SRP is required formembrane targeting of CyoA.A, proteasemapping
of CyoA-HA in Ffh depletion strain HDB51. HDB51 cells harboring a CyoA-HA expression
plasmid were grown under non-depleting or depleting conditions, pulse-labeled, con-
verted to spheroplasts, and treated with proteinase K as described under “Experimental
Procedures.” The samples were immunoprecipitated using antibodies directed against
the HA-tag (bottom panel) or antibodies directed against OmpA and trigger factor (top
panel). OmpA (outermembrane protein A) and trigger factor (cytoplasmic protein) were
analyzed to monitor the efficacy of proteinase K treatment and spheroplast formation,
respectively. Immunoprecipitatedmaterialwas analyzedby SDS-PAGE and visualizedby
phosphorimaging. B, immunoblot analysis of Ffh levels in 0.1 A660 units of cells used in
panel A. C, protease mapping of CyoA-HA in Ffh-87 mutant strain HTP406 and its wild-
type control strain (Ffh-wt). Both strains harboring a CyoA-HA expression plasmid were
grown in parallel, pulse-labeled, and converted to spheroplasts. Sampleswere prepared
and processed as described under A. The precursor and mature forms of CyoA-HA are
denoted p andm, respectively.
Biogenesis of CyoA
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arabinose-inducible promoter. Inactivation of SecY or depletion of SecE
results in the loss of the complete SecY/E core of the translocon. As
shown in Fig. 3A, inactivation of SecY had a strong effect on the acces-
sibility of CyoA toward proteinase K. Under control conditions, no
immunoprecipitable material of CyoA was left after proteinase K treat-
ment, confirming that the C-terminal tail is translocated and theHA tag
is degraded by proteinase K. However, upon inactivation of SecY,
mature CyoA was to a large extent converted into a protected proteo-
lytic fragment (pf) that migrated slightly faster than mature CyoA. This
form was absent when proteinase K was added to detergent-solubilized
spheroplasts (not shown). Most likely, this fragment represents mem-
brane-inserted mature CyoA with an untranslocated C terminus and a
translocated, hence degraded,N-terminal loop. Strikingly, processing of
CyoA was hardly affected under these conditions, indicating that signal
sequence insertion, lipid modification, and accessibility to SPaseII were
not perturbed.As a control, protease-protected proOmpAaccumulated
under these conditions (Fig. 3A), consistent with the well documented
role of the Sec machinery in the transfer of proOmpA across the inner
membrane (6). These results suggest that the small N-terminal domain
of CyoA upstream of TM1 does not require the Sec translocon to reach
the periplasmic side of the membrane, in contrast to the large C-termi-
nal domain. To confirm that the observed effects were due to inactiva-
tion of the SecY/E core of the translocon, the assembly of CyoAwas also
analyzed in the SecE depletion strain CM124. Depletion of SecE had a
similar effect on the translocation of the CyoA domains as inactivation
of SecY (data not shown).
The ATPase SecA is required to energize the translocation of large
periplasmic domains of IMPs through the SecYEG translocon (1). To
investigate whether SecA is involved in transfer of the large C-terminal
polar domain of CyoA, a protease accessibility experiment was carried
out in the absence or presence of azide to block SecA function (Fig. 3B).
In the absence of azide, no immunoprecipitable material was left after
proteinase K treatment, indicative of correct localization of the HA tag.
In the presence of azide, the same effect was observed as upon inactiva-
tion of SecY or depletion of SecE, strongly indicating that SecA is
required to catalyzemembrane transfer of theC-terminal polar domain.
However, translocation of the N-terminal region and signal sequence
cleavage processing were not affected by azide. Inhibition of SecA func-
tion by azide treatment was confirmed by a reduced processing
and translocation of proOmpA (Fig. 3B). Together, the results suggest
that the Sec translocon and SecA act in concert to translocate the CyoA
C terminus, whereas translocation of the N terminus neither requires
the Sec translocon or SecA.
YidC Is Required for Translocation and Membrane Assembly of the
CyoA N Terminus—To analyze the role of YidC in the membrane
assembly of CyoA, we used the YidC depletion strain JS7131 in which
the yidC gene is under control of an arabinose-inducible promoter (Fig.
3C). In the presence of YidC, the HA tag was correctly translocated
across the inner membrane and degraded by proteinase K. Depletion of
YidC resulted in inhibition of processing and accumulation of protease-
resistant precursorCyoA.As a control, the translocation and processing
ofOmpAwasmonitored and appeared unaffected, suggesting that inac-
tivation of the Sec translocon had not occurred under these conditions,
consistent with unaltered levels of Sec translocon components (data not
shown). YidCdepletionwas confirmed by analyzing the YidC content in
a cell sample taken before pulse labeling by immunoblotting using YidC
antiserum (Fig. 3D).
To study the localization of the accumulated CyoA precursor upon
depletion of YidC, spheroplasts derived from JS7131 cells depleted and
not depleted for YidC were subjected to sodium carbonate extraction,
which separates integral membrane proteins from peripheral mem-
brane proteins and soluble proteins. As expected, mature CyoA was
recovered in the carbonate-insoluble fraction in the presence of YidC,
indicative of an integral membrane localization (data not shown). Upon
depletion of YidC, the accumulated precursor CyoA was recovered in
the carbonate-insoluble fraction (data not shown), suggesting that YidC
is not required for the initial membrane insertion of CyoA.
The data indicate that YidC is required for translocation of theN-ter-
minal region and subsequent signal sequence cleavage. In the absence of
YidC, the C-terminal domain is also incapable of translocation, which is
probably due to an obligatory vectorial assembly fromN to C terminus.
Translocation of the N Terminus of CyoA Does Not Require the Sec
Translocon—The data so far indicate that membrane insertion and
translocation of the N and C terminus of CyoA follow different path-
ways. To further delineate the requirements for translocation of the
CyoA N terminus, we constructed a CyoA mutant that lacks TM2 and
the large polar C-terminal tail (Fig. 4A). The construct contains an HA
FIGURE 3.Distinct requirements for translocation of theN terminus and C terminus
of CyoA. A, protease mapping of CyoA-HA in the temperature-sensitive SecY mutant
strain IQ85 and its isogenic parent IQ86. Both strains harboring a CyoA-HA expression
plasmid were grown in parallel at 42 °C, pulse-labeled, and converted to spheroplasts.
Samples were prepared and processed as under Fig. 2A. B, protease mapping of
CyoA-HA in cells treated with azide to inhibit SecA function. Strain MC4100 harboring a
CyoA-HAexpressionplasmidwasgrown inM9medium,pulse-labeled in thepresenceor
absence of azide, and converted to spheroplasts. Sampleswere prepared andprocessed
as under Fig. 2A. C, protease mapping of CyoA-HA in YidC depletion strain JS7131. Cells
of strain JS7131 harboring a CyoA-HA expression plasmid were grown under non-de-
pleting or depleting conditions, pulse-labeled, and converted to spheroplasts. Samples
were prepared and processed as under Fig. 2A. D, immunoblot analysis of YidC levels in
0.1 A660 units of cells used in panel C. The precursor and mature forms of CyoA-HA are
denoted p andm, respectively. pf is the proteinase K proteolytic fragment of CyoA-HA.
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tag at the C terminus to enable immunodetection preceded by a posi-
tively charged stretch of four lysine residues to ensure correct topology
of the truncate. According to the positive inside rule, positively charged
residues of IMPs are predominantly localized at the cytoplasmic face of
the innermembrane and contribute to the topology of IMPs by prevent-
ing translocation of adjacent domains (1). Processing and topogenesis of
this CyoA-HA77–315 construct were verified using a protease acces-
sibility assay (Fig. 4B). In spheroplasts derived from awild-typeMC4100
strain, the construct is expressed and clipped at the N terminus by
externally added proteinase K, indicating that the construct is mem-
brane-integrated and has acquired its expected topology. The clipped
form is degraded in detergent-solubilized cells, confirming that this
form is not intrinsically protease-resistant but is inaccessible in intact
spheroplasts (Fig. 4B). Globomycin treatment caused an upward shift in
migration of the truncate, indicative of compromised processing, imply-
ing that the construct is normally lipid-modified and processed by
SPaseII. As expected and similar to the mature form, the N terminus of
the unprocessed precursor is clipped by proteinase K, resulting in a
slightly faster migrating protected species.
In subsequent experiments we investigated the requirements for
membrane assembly of CyoAHA77–315 using the conditional strains
described above. First, involvement of the Sec translocon was studied in
the SecE depletion strain CM124. Clearly, depletion of SecE had no
discernible effect on the processing or accessibility of CyoA-HA77–
315 toward proteinase K (Fig. 5A). Efficient depletion of SecE was con-
firmed by the reduced processing and translocation of OmpA (Fig. 5A).
Similar results were obtained using the temperature-sensitive SecY
mutant IQ85 and its isogenic control strain IQ86 (data not shown).
Next, YidC involvement was studied using the temperature-sensitive
YidC strain KO1672 and its isogenic control strain KO1670 (Fig. 5B).
Depletion of YidC strongly inhibited processing of CyoA-HA77–315,
resulting in accumulation of the precursor form that appeared mostly
inaccessible to proteolysis by proteinase K. Apparently, the N terminus
of the truncate is unable to reach the periplasm under these conditions.
Processing and translocation of OmpA appeared unaffected, demon-
strating that inactivation of the Sec translocon had not occurred. Deple-
tion of YidC was verified by analyzing the YidC content in a cell sample
taken before pulse labeling by immunoblotting (Fig. 5C). Together, the
in vivo results indicate that the N terminus of CyoA can insert inde-
pendent from the C terminus in a YidC-dependent, Sec-independent
mechanism.
Nascent CyoA Interacts with Ffh, SecY, SecE, and YidC—The in vivo
experiments described above indicate that efficient targeting andmem-
brane assembly of the complete CyoA protein requires the SRP, YidC,
the SecYEG translocon, and SecA. To independently confirm the con-
tribution of these factors, we used a combined in vitro translation/pho-
tocross-linking approach to evaluate the interactions of nascent CyoA
variants that are trapped during targeting and membrane assembly.
First, we analyzed the contacts of TM1 during biogenesis of CyoA. TM1
is more hydrophobic than the signal sequence (not shown) and, thus,
more likely to play a role in SRP-mediated membrane targeting (32).
Nascent chains of CyoA were synthesized in an E. coli cell-free extract
from truncated mRNA to a length of 118 residues and labeled by the
incorporation of [35S]methionine. Assuming that the ribosome covers
35 amino acids, the signal sequence and first TM are well exposed out
of the ribosome at this nascent chain length (Fig. 6A). The truncated
CyoA construct contained a single amber stop codon (TAG) at position
56 in the TM1 that was suppressed during in vitro translation by the
FIGURE 4. Membrane assembly of CyoA-HA77–315. A, topology model of CyoA-
HA77–315. This truncated CyoA derivative comprises the N-terminal signal sequence,
TM1, and the periplasmic domain in between. A stretch of four lysines was added to the
C terminus to anchor it at the cytoplasmic side of the innermembrane followedby anHA
tag to facilitate detection and verification of membrane assembly. In spheroplasts
derived fromwild-type cells, proteinase K degrades the translocated N terminus, result-
ing in a distinct proteolytic fragment. B, protease mapping of CyoA-HA77–315 in cells
treated with globomycin. MC4100 cells harboring a CyoA-HA77–315 expression plas-
mid were grown in M9medium and pulse-labeled in the presence or absence of globo-
mycin. Samples were prepared and processed as under Fig. 2A. The precursor form of
CyoA-HA77–315 is denoted p,m is the mature form, and pf is the proteinase K proteo-
lytic fragment. For clarity, the lipid-modified precursor is indicated by an arrowhead, and
the proteolytic fragment of the precursor is indicated by an asterisk.
FIGURE 5. Assembly of CyoA-HA77–315 requires YidC but not the Sec translocon.
A, protease mapping of CyoA-HA77–315 in SecE depletion strain CM124. Cells of
CM124 containing a CyoA-HA77–315 expression plasmid were grown under non-de-
pleting or depleting conditions, pulse-labeled, and converted to spheroplasts. Samples
were prepared and processed as under Fig. 2A. B, protease mapping of CyoA-HA77–
315 in the temperature-sensitive YidC strain KO1672 and its isogenic parent KO1670.
Both strains containingaCyoA-HA77–315expressionplasmidweregrown inparallel at
42 °C, pulse-labeled, and converted to spheroplasts. Samples were prepared and pro-
cessed as under Fig. 2A. C, immunoblot analysis of YidC levels in 0.1 A660 units of cells
used in panel B. The precursor form of CyoA-HA77–315 is denoted p, m is the mature
form, and pf is the proteinase K proteolytic fragment. For clarity, the precursor is indi-
cated by an arrowhead, and the mature form is indicated by an asterisk.
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addition of a suppressor tRNA that carried a phenylalanine with a pho-
to-activable Tmd group ((Tmd)-Phe-tRNAsup). This allowed us to spe-
cifically probe interactions of TM1 in nascent CyoA.We confirmed that
the TAG mutation was efficiently suppressed by the (Tmd)Phe-
tRNAsup, resulting in nascent CyoA of the expected molecular weight
(not shown). Next, 118CyoA-TAG56 was synthesized in the absence of
inverted membrane vesicles and UV-irradiated to activate the cross-
linking probe and secure contacts of the CyoA TM1 in the E. coli
cytosol. A prominent cross-linking product of60 kDa was generated
that could be immunoprecipitated using anti-Ffh serum (Fig. 6B, lane
2). This suggests association of TM1with the SRP, consistentwith the in
vivo SRP data described above.
To investigate the contacts of 118CyoA-TAG56 during membrane
assembly, inverted membrane vesicles were added during translation,
allowing co-translational membrane insertion of nascent CyoA. Subse-
quent cross-linking induced by UV irradiation and recovery of the
membrane-integrated nascent chains by sodium carbonate extraction
generated cross-linking products of 70 and 45 kDa in which YidC
and SecY were identified as partners by immunoprecipitation (Fig. 6B,
lanes 4 and 5). Moreover, a weak band at 29 kDa represented cross-
linking to SecE (Fig. 6B, lane 6). This indicates that TM1 of nascent
CyoA is primarily in contact with YidC and SecY at this stage during
membrane insertion.
To probe initial interactions from the signal sequence, 54CyoA-
TAG10 was constructed in which the signal sequence (with a
photocross-link probe in the core region) is expected to be exposed
outside the ribosome. Notably, cross-linking was restricted to TF and
the ribosomal protein L23; no significant cross-linking was observed to
Ffh or membrane components (data not shown). These results are con-
sistent with the relatively modest hydrophobicity of the signal sequence
and previously obtained cross-link data using other signal sequences of
similar hydrophobicity (15, 32). Together, the cross-link data argue that
TM1 recruits the SRP for targeting of nascent CyoA and inserts into the
membrane at the Sec-YidC insertase.
DISCUSSION
CyoA is one of the four integral membrane subunits of the cyto-
chrome o oxidase complex in the E. coli inner membrane. CyoA is an
unusual polytopic IMP in the sense that it is synthesized with an N-ter-
minal, lipoprotein type signal sequence that is cleaved from the precur-
sor protein (23). This generates mature CyoA with two hydrophobic
TMs and an N-terminal cysteine residue that is probably anchored to
the inner membrane via three covalently attached acyl chains. It has
been recently shown that, unlikemost other polytopic IMPs, the level of
CyoA in the inner membrane drops dramatically upon depletion of
YidC, suggesting an important role of YidC in the biogenesis of CyoA
(19). Evidence presented in this work suggests that YidC is required and
sufficient for assembly of the N-terminal region, explaining its pivotal
role in the assembly of the complete CyoA that probably proceeds in a
vectorial co-translational mechanism.
In Fig. 7 a model is depicted that describes the targeting and mem-
brane assembly of CyoA based on the in vivo protease mapping and in
vitro cross-linking experiments described in this study. The SRP targets
nascent CyoA via TM1 to the insertion site in the membrane judged by
the observation that precursor CyoA accumulates in the cells in three
SRP mutant strains under conditions where proOmpA, an outer mem-
brane protein that is targeted via the SecB pathway, is normally pro-
cessed. The in vitro cross-link experiments suggest that co-translational
targeting is not initiated until TM1 is exposed at the ribosomal nascent
chain exit site and associates with Ffh. The signal sequence emerging
from the ribosome in shorter nascent chains does not contact the SRP
nor inserts stably into the membrane. Rather, at this stage the signal
sequence is proximal to the chaperone trigger factor and the ribosomal
protein L23. The recently presented crystal structure of a ribosome-
trigger factor complex demonstrates that trigger factor binds to L23
near the nascent chain exit site, arching over the exit region and, thus,
providing a secluded cavity (33). This architecture may prevent prema-
ture contact of nascent CyoA with the translocon. Selection of TM1
rather than the signal sequence by the SRP is probably dictated by the
more hydrophobic core of TM1 that is clearly above the threshold level
for SRP binding in contrast to the much less hydrophobic core of the
signal sequence (not shown).
At this stage, TF and SRPmay sequester the signal sequence andTM1
near L23 to facilitate the formation of a hairpin-like conformation that is
required for the subsequent concertedmembrane integration at YidCof
the signal sequence, TM1, and intercalated periplasmic domain that
contains the SPaseII cleavage site. The SRP is proposed to guide the
ribosome-nascent CyoA complex to YidC, but mechanistic details of
this step and a possible involvement of the SRP receptor FtsY remain
unclear. Interestingly, in thylakoid membranes a functional interaction
between chloroplast SRP, FtsY, and the YidC homologue Alb3 has been
FIGURE 6. The molecular environment of nascent CyoA. A, schematic representation
of the nascent CyoA 118-mer with a photocross-linking probe at position 56. The TMs
and signal sequence (SS) are indicated. B, in vitro translation of nascent CyoAwas carried
out in the presence of (Tmd)Phe-tRNAsup in the absence (lanes 1 and 2) or presence of
inverted membrane vesicles (IMVs) (lanes 3–6). After translation, samples were either
UV-irradiated and acid-precipitated (lanes 1 and 2) or extracted with sodium carbonate
(lane 3-6). Acid precipitates and carbonate pellet fractionswere immunoprecipitated (IP)
using antisera against the indicatedproteins (lanes 2 and 4–6) or directly analyzed (lanes
1 and 3).
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demonstrated (34). It should be noted, however, that involvement of the
SRP in targeting of Foc, another IMP that requires YidC for membrane
insertion, is controversial (20–22). Targeting of membrane proteins via
the second hydrophobic sequence is not unprecedented. Studies on the
insertion of M13 procoat, the cystic fibrosis transmembrane regulator
(CFTR), and the Shaker-like K channel revealed a prominent role for
the second, more hydrophobic sequence in targeting and initiation of
membrane insertion (M13 procoat) or TM1 (CFTR, Shaker-like K
channel) (35–37).
If not necessary for targeting per se, what is the role for the CyoA signal
sequence? It may be required to transfer the N-terminal hydrophilic
domain in between the signal sequence andTM1 to the periplasmic side of
the membrane in a concerted hairpin-type insertion. Notably, deletion of
Arg-2 to Ser-9 of theCyoA signal sequence eliminates incorporation of the
oxidase in the membrane, although the stage of the defect was not deter-
mined (23). Furthermore, lipid modification of the conserved N-terminal
cysteine, located at the SPaseII cleavage site, might be required to anchor
theN terminus in themembrane. Interestingly,mutation of this conserved
cysteine into an alanine abolishes lipid modification and signal sequence
cleavage but does not affect membrane assembly and functioning of the
oxidase (23). In this mutant the uncleaved signal sequence probably func-
tions as an additional TM, anchoring the downstream sequence to the
membrane in the absence of lipid modification.
Translocation of the periplasmic loop that precedes TM1 in CyoA
requires YidC, whereas the Sec machinery is dispensable. Interestingly,
the structure of the ubiquinol oxidase shows that this loop is only 11
residues long including one negatively and one positively charged resi-
due (38). It has been demonstrated recently that YidC is necessary and
sufficient for translocation of the periplasmic domain in between the
signal sequence and TM1 ofM13 procoat (39). It was shown that trans-
location of this loop only becomes Sec-dependent when the net number
of negatively charges (3 in wild type) or the length of the loop (20
residues in wild type) is increased (39). Apparently, YidC is able to
translocate small, relatively uncharged domains in between a signal
sequence and a TM. It remains to be investigated whether this translo-
cation involves a channel-like property of YidC or whether it is a “side
effect” of YidC-assisted formation of transmembrane helices.
Cross-linking of membrane-inserted nascent CyoA in which both the
signal sequence andTM1have emerged fromthe ribosome revealed that at
this stage TM1 is not only close to YidC, as expected, but also to SecY and
SecE, which are only needed at a later stage in translation when TM2 is
inserted and the large C-terminal domain is translocated into the
periplasm. Possibly, the Sec translocon is already recruited near the YidC
insertase in response to sequences of CyoA that are still buried in the ribo-
somal exit tunnel. Alternatively, the YidC insertase is permanently or
dynamically connectedwith the Sec translocon. In this respect, it should be
noted that there is no direct evidence for strictly separate pools of
Sec-associated and “free” YidC. Interestingly, a cryo electron microscopy
reconstruction of the dimeric E. coli SecYEG channel tethered to a ribo-
some-nascent FtsQ complex has been reported very recently, giving an
impressionof the transloconstructure caught in theactof insertingamem-
brane protein (40). The structure suggests a dynamic and asymmetric dis-
tribution of features with greater lipid accessibility at the front of the chan-
nel. As proposed by the authors, YidC could be situated near this front side
to regulate the transfer of nascentpeptidesbetween the lipidbilayer and the
interior of the Sec translocon.
Clearly, the Sec translocon is required for translocation of the large
(200 residues) periplasmic domain downstream of TM2. Most likely,
TM2 acts as a signal anchor sequence and inserts in the SecYEG trans-
locon to initiate translocation of the C terminus in a SecA-dependent
manner (Fig. 7). This step is probably mechanistically similar to the
assembly and translocation of other large periplasmic domains in IMPs
such as those present in FtsQ and Lep (1). It remains uncertain whether
TM1 is kept near YidC at this stage before its transfer into the lipid
bilayer. Finally, TM2 shouldmove laterally from the Sec translocon into
the lipid bilayer, possibly via YidC, and assemble with TM1 into the
tightly packed hetero-oligomeric oxidase complex. Notably, these latter
steps were not explored by cross-linking and remain speculative.
In conclusion, we have presented evidence that membrane assembly
of CyoA occurs in two distinct sequential steps. Although the precise
molecular mechanism awaits further analysis, the data suggest that in
this case the Sec translocase operates downstreamof the YidC insertase,
explaining the strongly reduced levels of CyoA in the inner membrane
upon depletion of YidC. It remains to be investigated whether other
membrane proteins follow this pathway for membrane integration. It is
of interest that the data are to some extent reminiscent of Lep, a model
IMP that has been extensively used in biogenesis studies. Lep has the
same overall topology as CyoA (2 TMs, small N-terminal and large
C-terminal periplasmic domain) but is synthesized without an N-ter-
minal signal sequence. Lep is targeted by the SRP that interacts with
TM1 (32, 41). Similar to CyoA, translocation of the small N-terminal
periplasmic domain does not require the Sec machinery, in contrast to
FIGURE 7.Model for themembrane assembly of
CyoA. Themodel is described under “Discussion.”
The (transient) association between YidC and the
SecYEG complex is indicated by a double arrow.
RNC, ribosome nascent chain complex.
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the large periplasmic domain downstream of TM2 (42). On the other
hand, depletion of YidC has little effect on the overall assembly of Lep
(10), indicating that Lep is rather flexible in the use of different insertase
components, in contrast to the proposed hairpin-type insertion of the
signal sequence/TM1pair inCyoA andM13 procoat that appear strictly
YidC-dependent.
Interestingly, Cox2p, the CyoA homologue in the innermembrane of
mitochondria in Saccharomyces cerevisiae, displays similar distinct
requirements for membrane assembly; the YidC homologue Oxa1p is
required for translocation of both theN andC terminus across the inner
membrane into the intermembrane space (43, 44), whereas a distant
YidC homologue, Cox18 (Oxa2p), is specifically involved in topogenesis
of the C-terminal domain (45, 46). Therefore, despite the fact thatmito-
chondria do not contain a Sec translocon, the principle of a segmented
insertion mechanism appears conserved.
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